ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 089,49
-0,64%
Dow Jones
39 872,99
0,17%
DAX
18 649,39
-0,41%
Brent Oil
82,11
-0,41%
Bitcoin
69 903,44
-0,32%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Derma Sciences, Inc. (DSCI)

  7. Derma Sciences, Inc. (DSCI) Actualités

DSCI

Derma Sciences, Inc. (DSCI)

Derma Sciences, Inc.
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DSCI
DateHeureSourceTitreSymboleSociété
02/02/201818h30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DSCIDerma Sciences, Inc.
21/03/201711h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DSCIDerma Sciences, Inc.
15/03/201719h26Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:DSCIDerma Sciences, Inc.
07/03/201722h04Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:DSCIDerma Sciences, Inc.
07/03/201712h05Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:DSCIDerma Sciences, Inc.
28/02/201718h35Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DSCIDerma Sciences, Inc.
24/02/201723h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSCIDerma Sciences, Inc.
24/02/201715h27Edgar (US Regulatory)(25-NSE)NASDAQ:DSCIDerma Sciences, Inc.
24/02/201715h03Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DSCIDerma Sciences, Inc.
24/02/201714h45Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:DSCIDerma Sciences, Inc.
24/02/201714h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DSCIDerma Sciences, Inc.
23/02/201714h45Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DSCIDerma Sciences, Inc.
23/02/201714h39Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DSCIDerma Sciences, Inc.
23/02/201714h30GlobeNewswire Inc.Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.NASDAQ:DSCIDerma Sciences, Inc.
25/01/201722h42Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:DSCIDerma Sciences, Inc.
25/01/201722h18Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:DSCIDerma Sciences, Inc.
25/01/201714h30GlobeNewswire Inc.Integra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences, Inc.NASDAQ:DSCIDerma Sciences, Inc.
23/01/201717h10Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:DSCIDerma Sciences, Inc.
17/01/201723h26PR Newswire (US)Harwood Feffer LLP Announces Investigation of Derma Sciences Inc.NASDAQ:DSCIDerma Sciences, Inc.
17/01/201722h42Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:DSCIDerma Sciences, Inc.
12/01/201712h03Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:DSCIDerma Sciences, Inc.
11/01/201722h15Business WireDerma Sciences Buys MEDIHONEY® Brand From Long-Term PartnerNASDAQ:DSCIDerma Sciences, Inc.
11/01/201717h05Business WireDERMA SCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutNASDAQ:DSCIDerma Sciences, Inc.
11/01/201715h33PR Newswire (US)DERMA (DSCI) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale o...NASDAQ:DSCIDerma Sciences, Inc.
11/01/201702h00Business WireDerma Sciences to Be Acquired by Integra LifeSciences for $7.00 Per Share of Common Stock in CashNASDAQ:DSCIDerma Sciences, Inc.
11/01/201702h00GlobeNewswire Inc.Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Res...NASDAQ:DSCIDerma Sciences, Inc.
09/01/201712h00GlobeNewswire Inc.Immunomedics Announces Reconstituted Board of Directors and Leadership Succession PlanNASDAQ:DSCIDerma Sciences, Inc.
10/11/201622h00Business WireDerma Sciences to Present at the Canaccord Genuity Medical Technologies & Diagnostics ForumNASDAQ:DSCIDerma Sciences, Inc.
10/11/201613h30Business WireDerma Sciences Reports 2016 Third Quarter Financial ResultsNASDAQ:DSCIDerma Sciences, Inc.
09/11/201623h24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DSCIDerma Sciences, Inc.
 Showing the most relevant articles for your search:NASDAQ:DSCI

Dernières Valeurs Consultées

NASDAQ
FPVSXX
Capital Strength Portfol...
USOTC
DANR
Dana Resources (CE)
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés